Valvulopathy or primary pulmonary hypertension as possible consequences of administering a serotonin uptake blocker with a monoamine oxidase inhibitor ('phen-fen')

Cardiovascular Reviews and Reports

Volumn 20, Issue 6, 1999, Pages 312-314

  Wurtman, R J ^a   Maher, T J ^a   Coplan, N L ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; FLUOXETINE; IPRONIAZID; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PHENTERMINE; SEROTONIN UPTAKE INHIBITOR;

DRUG EFFECT; ECHOCARDIOGRAPHY; EDITORIAL; ENZYME INHIBITION; HUMAN; NEUROTRANSMITTER RELEASE; PULMONARY HYPERTENSION; SEROTONIN METABOLISM; VALVULAR HEART DISEASE;

EID: 0033053102     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)